CLINICAL_TRIALS
trial_result
· 2013-01-24
Clinical Trial Update: Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study [Phase 3]
Summary
The Phase 3 EINSTEIN DVT trial evaluated rivaroxaban for the treatment of acute symptomatic deep vein thrombosis; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Venous Thrombosis | Phase 3 | Status: COMPLETED | Results posted: 2013-01-24